Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Nat Methods ; 21(3): 423-434, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38374261

ABSTRACT

Different regions of RNA molecules can often engage in specific interactions with distinct RNA-binding proteins (RBPs), giving rise to diverse modalities of RNA regulation and function. However, there are currently no methods for unbiased identification of RBPs that interact with specific RNA regions in living cells and under endogenous settings. Here we introduce TREX (targeted RNase H-mediated extraction of crosslinked RBPs)-a highly sensitive approach for identifying proteins that directly bind to specific RNA regions in living cells. We demonstrate that TREX outperforms existing methods in identifying known interactors of U1 snRNA, and reveals endogenous region-specific interactors of NORAD long noncoding RNA. Using TREX, we generated a comprehensive region-by-region interactome for 45S rRNA, uncovering both established and previously unknown interactions that regulate ribosome biogenesis. With its applicability to different cell types, TREX is an RNA-centric tool for unbiased positional mapping of endogenous RNA-protein interactions in living cells.


Subject(s)
RNA-Binding Proteins , RNA , RNA/genetics , RNA-Binding Proteins/genetics , RNA-Binding Proteins/metabolism
2.
EMBO J ; 42(11): e110902, 2023 06 01.
Article in English | MEDLINE | ID: mdl-37039106

ABSTRACT

Oncogenic RAS signaling reprograms gene expression through both transcriptional and post-transcriptional mechanisms. While transcriptional regulation downstream of RAS is relatively well characterized, how RAS post-transcriptionally modulates gene expression to promote malignancy remains largely unclear. Using quantitative RNA interactome capture analysis, we here reveal that oncogenic RAS signaling reshapes the RNA-bound proteomic landscape of pancreatic cancer cells, with a network of nuclear proteins centered around nucleolin displaying enhanced RNA-binding activity. We show that nucleolin is phosphorylated downstream of RAS, which increases its binding to pre-ribosomal RNA (rRNA), boosts rRNA production, and promotes ribosome biogenesis. This nucleolin-dependent enhancement of ribosome biogenesis is crucial for RAS-induced pancreatic cancer cell proliferation and can be targeted therapeutically to inhibit tumor growth. Our results reveal that oncogenic RAS signaling drives ribosome biogenesis by regulating the RNA-binding activity of nucleolin and highlight a crucial role for this mechanism in RAS-mediated tumorigenesis.


Subject(s)
Genes, ras , Pancreatic Neoplasms , Humans , MAP Kinase Signaling System , Proteomics , Phosphoproteins/metabolism , RNA, Ribosomal/metabolism , RNA/metabolism , Cell Transformation, Neoplastic/genetics , Ribosomes/genetics , Ribosomes/metabolism , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/metabolism , Nucleolin
3.
Sci Signal ; 14(691)2021 07 13.
Article in English | MEDLINE | ID: mdl-34257105

ABSTRACT

Synaptic plasticity involves structural modifications in dendritic spines that are modulated by local protein synthesis and actin remodeling. Here, we investigated the molecular mechanisms that connect synaptic stimulation to these processes. We found that the phosphorylation of isoform-specific sites in eEF1A2-an essential translation elongation factor in neurons-is a key modulator of structural plasticity in dendritic spines. Expression of a nonphosphorylatable eEF1A2 mutant stimulated mRNA translation but reduced actin dynamics and spine density. By contrast, a phosphomimetic eEF1A2 mutant exhibited decreased association with F-actin and was inactive as a translation elongation factor. Activation of metabotropic glutamate receptor signaling triggered transient dissociation of eEF1A2 from its regulatory guanine exchange factor (GEF) protein in dendritic spines in a phosphorylation-dependent manner. We propose that eEF1A2 establishes a cross-talk mechanism that coordinates translation and actin dynamics during spine remodeling.


Subject(s)
Actins , Dendritic Spines , Peptide Elongation Factor 1/metabolism , Protein Biosynthesis , Actin Cytoskeleton , Actins/genetics , Neuronal Plasticity , Neurons
4.
Science ; 372(6543)2021 05 14.
Article in English | MEDLINE | ID: mdl-33986153

ABSTRACT

Aberrant alternative splicing is a hallmark of cancer, yet the underlying regulatory programs that control this process remain largely unknown. Here, we report a systematic effort to decipher the RNA structural code that shapes pathological splicing during breast cancer metastasis. We discovered a previously unknown structural splicing enhancer that is enriched near cassette exons with increased inclusion in highly metastatic cells. We show that the spliceosomal protein small nuclear ribonucleoprotein polypeptide A' (SNRPA1) interacts with these enhancers to promote cassette exon inclusion. This interaction enhances metastatic lung colonization and cancer cell invasion, in part through SNRPA1-mediated regulation of PLEC alternative splicing, which can be counteracted by splicing modulating morpholinos. Our findings establish a noncanonical regulatory role for SNRPA1 as a prometastatic splicing enhancer in breast cancer.


Subject(s)
Alternative Splicing , Breast Neoplasms/pathology , Neoplasm Metastasis/genetics , RNA/genetics , RNA/metabolism , Ribonucleoprotein, U2 Small Nuclear/metabolism , Adaptor Proteins, Signal Transducing/genetics , Algorithms , Animals , Binding Sites , Breast Neoplasms/genetics , Cell Line, Tumor , Disease Progression , Exons , Gene Knockdown Techniques , Humans , Lung Neoplasms/secondary , Mice , Mice, Inbred NOD , Mice, SCID , Neoplasm Invasiveness , Neoplasm Transplantation , Nucleic Acid Conformation , Plectin/genetics , Protein Binding , RNA Interference , RNA, Small Nuclear/chemistry , RNA, Small Nuclear/metabolism , RNA-Seq , Ribonucleoprotein, U2 Small Nuclear/genetics , Software , Spliceosomes/metabolism , Tumor Suppressor Proteins/genetics
5.
STAR Protoc ; 2(2): 100462, 2021 06 18.
Article in English | MEDLINE | ID: mdl-33912849

ABSTRACT

Actin-rich protrusions are membrane extensions generated by actin polymerization that drive mesenchymal-like cell migration. Characterization of protrusions proteome is crucial for understanding their function. We present a complete step-by-step protocol based on microporous filter-based fractionation of protrusive cellular domains coupled with sample preparation for quantitative proteomics, mass spectrometric data acquisition, and data analysis. This protocol enables purification, quantification, and analysis of the distribution of proteins present in protrusions and cell bodies. For complete details on the use and execution of this protocol, please refer to Dermit et al. (2020).


Subject(s)
Cell Body , Cell Surface Extensions , Proteomics , Cell Body/chemistry , Cell Body/metabolism , Cell Line, Tumor , Cell Surface Extensions/chemistry , Cell Surface Extensions/metabolism , Humans
6.
J Proteome Res ; 20(4): 1972-1980, 2021 04 02.
Article in English | MEDLINE | ID: mdl-33325715

ABSTRACT

Shotgun proteomics techniques infer the presence and quantity of proteins using peptide proxies produced by cleavage of the proteome with a protease. Most protein quantitation strategies assume that multiple peptides derived from a protein will behave quantitatively similar across treatment groups, but this assumption may be false due to (1) heterogeneous proteoforms and (2) technical artifacts. Here we describe a strategy called peptide correlation analysis (PeCorA) that detects quantitative disagreements between peptides mapped to the same protein. PeCorA fits linear models to assess whether a peptide's change across treatment groups differs from all other peptides assigned to the same protein. PeCorA revealed that ∼15% of proteins in a mouse microglia stress data set contain at least one discordant peptide. Inspection of the discordant peptides shows the utility of PeCorA for the direct and indirect detection of regulated post-translational modifications (PTMs) and also for the discovery of poorly quantified peptides. The exclusion of poorly quantified peptides before protein quantity summarization decreased false-positives in a benchmark data set. Finally, PeCorA suggests that the inactive isoform of prothrombin, a coagulation cascade protease, is more abundant in plasma from COVID-19 patients relative to non-COVID-19 controls. PeCorA is freely available as an R package that works with arbitrary tables of quantified peptides.


Subject(s)
Peptides/analysis , Proteomics , Animals , COVID-19/blood , Humans , Mice , Microglia , Protein Processing, Post-Translational , Proteome , Prothrombin/analysis
7.
Dev Cell ; 55(3): 298-313.e10, 2020 11 09.
Article in English | MEDLINE | ID: mdl-33171110

ABSTRACT

Translation of ribosomal protein-coding mRNAs (RP-mRNAs) constitutes a key step in ribosome biogenesis, but the mechanisms that modulate RP-mRNA translation in coordination with other cellular processes are poorly defined. Here, we show that subcellular localization of RP-mRNAs acts as a key regulator of their translation during cell migration. As cells migrate into their surroundings, RP-mRNAs localize to the actin-rich cell protrusions. This localization is mediated by La-related protein 6 (LARP6), an RNA-binding protein that is enriched in protrusions. Protrusions act as hotspots of translation for RP-mRNAs, enhancing RP synthesis, ribosome biogenesis, and the overall protein synthesis in migratory cells. In human breast carcinomas, epithelial-to-mesenchymal transition (EMT) upregulates LARP6 expression to enhance protein synthesis and support invasive growth. Our findings reveal LARP6-mediated mRNA localization as a key regulator of ribosome biogenesis during cell migration and demonstrate a role for this process in cancer progression downstream of EMT.


Subject(s)
Cell Movement , Organelle Biogenesis , RNA Transport , Ribosomes/metabolism , Autoantigens/metabolism , Cell Proliferation , Cell Surface Extensions/metabolism , Epithelial-Mesenchymal Transition , Humans , Neoplasms/metabolism , Neoplasms/pathology , Protein Binding , Protein Biosynthesis , RNA, Messenger/genetics , RNA, Messenger/metabolism , Ribonucleoproteins/metabolism , Ribosomal Proteins/metabolism , Subcellular Fractions/metabolism , Transcriptome/genetics , SS-B Antigen
8.
Cancer Discov ; 10(9): 1410-1423, 2020 09.
Article in English | MEDLINE | ID: mdl-32513775

ABSTRACT

Identifying master regulators that drive pathologic gene expression is a key challenge in precision oncology. Here, we have developed an analytic framework, named PRADA, that identifies oncogenic RNA-binding proteins through the systematic detection of coordinated changes in their target regulons. Application of this approach to data collected from clinical samples, patient-derived xenografts, and cell line models of colon cancer metastasis revealed the RNA-binding protein RBMS1 as a suppressor of colon cancer progression. We observed that silencing RBMS1 results in increased metastatic capacity in xenograft mouse models, and that restoring its expression blunts metastatic liver colonization. We have found that RBMS1 functions as a posttranscriptional regulator of RNA stability by directly binding its target mRNAs. Together, our findings establish a role for RBMS1 as a previously unknown regulator of RNA stability and as a suppressor of colon cancer metastasis with clinical utility for risk stratification of patients. SIGNIFICANCE: By applying a new analytic approach to transcriptomic data from clinical samples and models of colon cancer progression, we have identified RBMS1 as a suppressor of metastasis and as a post-transcriptional regulator of RNA stability. Notably, RBMS1 silencing and downregulation of its targets are negatively associated with patient survival.See related commentary by Carter, p. 1261.This article is highlighted in the In This Issue feature, p. 1241.


Subject(s)
Colonic Neoplasms/pathology , DNA-Binding Proteins/metabolism , Gene Expression Regulation, Neoplastic , Liver Neoplasms/genetics , RNA, Messenger/genetics , RNA-Binding Proteins/metabolism , Animals , Cell Line, Tumor , Colon/pathology , Colonic Neoplasms/diagnosis , Colonic Neoplasms/genetics , DNA-Binding Proteins/genetics , Gene Knockdown Techniques , Humans , Intestinal Mucosa/pathology , Liver Neoplasms/secondary , Male , Mice , Neoplasm Staging , RNA Stability/genetics , RNA-Binding Proteins/genetics , RNA-Seq , Regulon , Xenograft Model Antitumor Assays
9.
Development ; 147(4)2020 02 26.
Article in English | MEDLINE | ID: mdl-32054660

ABSTRACT

La-related protein 6 (Larp6) is a conserved RNA-binding protein found across eukaryotes that has been suggested to regulate collagen biogenesis, muscle development, ciliogenesis, and various aspects of cell proliferation and migration. Zebrafish have two Larp6 family genes: larp6a and larp6b Viable and fertile single and double homozygous larp6a and larp6b zygotic mutants revealed no defects in muscle structure, and were indistinguishable from heterozygous or wild-type siblings. However, larp6a mutant females produced eggs with chorions that failed to elevate fully and were fragile. Eggs from larp6b single mutant females showed minor chorion defects, but chorions from eggs laid by larp6a;larp6b double mutant females were more defective than those from larp6a single mutants. Electron microscopy revealed defective chorionogenesis during oocyte development. Despite this, maternal zygotic single and double mutants were viable and fertile. Mass spectrometry analysis provided a description of chorion protein composition and revealed significant reductions in a subset of zona pellucida and lectin-type proteins between wild-type and mutant chorions that paralleled the severity of the phenotype. We conclude that Larp6 proteins are required for normal oocyte development, chorion formation and egg activation.


Subject(s)
Autoantigens/genetics , Autoantigens/physiology , Chorion/physiology , Oocytes/physiology , Ribonucleoproteins/genetics , Ribonucleoproteins/physiology , Animals , Cell Movement , Cell Proliferation , Collagen/physiology , Egg Proteins/physiology , Female , Gene Editing , Gene Expression Profiling , Gene Expression Regulation, Developmental , Genome , Genotype , Heterozygote , Homozygote , Lectins/physiology , Male , Mutation , Oocytes/cytology , Oogenesis/physiology , Phenotype , Zebrafish , Zona Pellucida/physiology , SS-B Antigen
10.
Mol Biosyst ; 13(12): 2477-2488, 2017 Nov 21.
Article in English | MEDLINE | ID: mdl-29051942

ABSTRACT

Regulation of protein translation constitutes a crucial step in control of gene expression. In comparison to transcriptional regulation, however, translational control has remained a significantly under-studied layer of gene expression. This trend is now beginning to shift thanks to recent advances in next-generation sequencing, proteomics, and microscopy based methodologies which allow accurate monitoring of protein translation rates, from single target messenger RNA molecules to genome-wide scale studies. In this review, we summarize these recent advances, and discuss how they are enabling researchers to study translational regulation in a wide variety of in vitro and in vivo biological systems, with unprecedented depth and spatiotemporal resolution.


Subject(s)
Protein Transport/physiology , Animals , Gene Expression Profiling , Gene Expression Regulation , Humans , Protein Biosynthesis , Protein Transport/genetics , RNA, Messenger , Ribosomes/metabolism
11.
FEBS Lett ; 591(17): 2577-2592, 2017 09.
Article in English | MEDLINE | ID: mdl-28691371

ABSTRACT

Cells integrate extracellular signals into appropriate responses through a complex network of biochemical reactions driven by the activity of protein and lipid kinases, among other proteins. In order to understand this complexity, new approaches, both experimental and computational, have recently been developed with the aim to identify regulatory kinases and infer their activation status in the context of their signalling network. Here, we review such approaches with particular focus on those based on phosphoproteomics. Integration of kinase activity measurements inferred from phosphoproteomics data with other 'omics' datasets is starting to be used to identify regulatory nodes in biochemical networks. These methodologies may in the future be used to identify patient-specific targets and thus advance personalised cancer medicine.


Subject(s)
Neoplasms/enzymology , Neoplasms/pathology , Protein Kinases/metabolism , Proteomics/methods , Signal Transduction , Animals , Gene Expression Regulation, Neoplastic , Humans , Neoplasms/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...